Navigation Links
AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
Date:10/19/2009

COLD SPRING HARBOR, N.Y., Oct. 19 /PRNewswire/ -- AccuVein LLC today announced a five-year agreement with the Ferrer Group, a leading international pharmaceutical and medical devices distribution company, providing the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to customers in Greece, Spain and Portugal. The AccuVein AV300 helps healthcare professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on a patient's skin that reveals vein position.

"Ferrer Group's broad customer base share a common desire - to use advanced medical technology products that add value to reducing costs and improving patient care," said Jose Luis Lirio, Ferrer Group. "We're pleased to bring the world's only portable vein illumination device into our distribution."

"This agreement significantly expands the AV300's global availability into these important markets," said Stephen P. Conlon, President of AccuVein. "Healthcare practitioners in Greece, Spain and Portugal now have access to the device to reduce time and effort in accessing veins."

For more information on the AccuVein AV300, please visit www.AccuVein.com.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of peripheral veins, helping caregivers locate these veins while they perform the most common invasive medical procedure - venipuncture. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

About Ferrer Group

Ferrer Group is comprised of over 50 companies operating in Pharmacy, Food and Fine Chemicals, three key areas to assist in improving health and quality of life of people. Grupo Ferrer Internacional serves customers in France, Italy, Belgium, Portugal, and Greece, as well as in Spain, Germany, the Middle East, South America, Africa, and the Far East. Grupo Ferrer Internacional, S.A. was founded in 1959 and is based in Barcelona, Spain.

SOURCE AccuVein LLC


'/>"/>
SOURCE AccuVein LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
2. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
3. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
4. New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
5. New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
6. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
7. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
8. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
9. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
10. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
11. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  "Blood Tests replace Surgical Biopsies. Single screening ... Diagnostic, Monitoring and Screening Test opportunities are explored. ... using in vitro blood testing to identify cancer ... has announced a single blood test to detect ... the market. New technology that definitively identifies disease ...
(Date:12/6/2016)... 6, 2016 Anaplastic Oligoastrocytoma - Pipeline ... Direct,s latest Pharmaceutical and Healthcare disease pipeline guide ... an overview of the Anaplastic Oligoastrocytoma (Oncology) pipeline ... that forms when two types of cells in ... in number to form a mass. These brain ...
(Date:12/6/2016)... , Dec. 6, 2016 Eurofins ... accreditation from the College of American Pathologists (CAP) ... (CLIA) for its new laboratory in ... moved its North American headquarters. "Our ... sequencing -- which is still considered the ,Gold ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 07, 2016 , ... The Cliff Hart Agencies, a Michigan-based ... Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, is announcing a regional ... tumor. , Jason Bauer and his family are longtime members of the Williamston ...
(Date:12/7/2016)... ... 2016 , ... AlignLife clinics nationwide are giving back to their communities by ... receive bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread ... world. , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... 07, 2016 , ... The Honolulu cosmetic and medical dermatology ... launched October 17, 2016, features comprehensive information regarding a wide range of dermatologic ... patients can discover the latest clinical dermatology treatments for medical skin concerns as ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s Live ... the Folio: Marketing Awards competition. Live From won in the Use of Social ... and ultimately successful projects undertaken by the media industry’s most innovative marketing professionals. ...
(Date:12/7/2016)... , ... December 07, 2016 ... ... announced its newest portable bioelectronic medicine device WellnessPro Plus for consumers and ... substantially enhances the WellnessPro platform by expanding the treatment modalities available in ...
Breaking Medicine News(10 mins):